Lv11
35 积分 2021-01-21 加入
Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA‐AUT
1小时前
待确认
Emerging disease-modifying therapies for Angelman syndrome: A comprehensive review for pediatric neurologists
21天前
已完结
An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the UBE3A-AS transcript
21天前
已完结
The Unified Myoclonus Rating Scale
26天前
已关闭
MDS clinical diagnostic criteria for Parkinson's disease
30天前
已完结
A severity scoring tool to assess the neurological features of neuronopathic Gaucher disease
1个月前
已完结
Four-year follow-up of chronic neuronopathic Gaucher disease in Europeans using a modified severity scoring tool
1个月前
已完结
First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial
1个月前
已完结
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
1个月前
已完结
Safety and efficacy of venglustat in GBA1-associated Parkinson's disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
3个月前
已完结
皖公网安备34019202002308
